human melanoma cell lines a375 Search Results


94
CLS Cell Lines Service GmbH a375 cells
A375 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/custom%40300110%4010%2E1007%2Fs11243-013-9777-6?v=CLS+Cell+Lines+Service+GmbH
Average 94 stars, based on 1 article reviews
a375 cells - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
SecuGen Corporation human melanoma cell line a375
Human Melanoma Cell Line A375, supplied by SecuGen Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/10__1158_slash_0008___5472__can___18___2762-40-1-13?v=SecuGen+Corporation
Average 90 stars, based on 1 article reviews
human melanoma cell line a375 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
VASCO DRUG LABORATORIES g77 strain
G77 Strain, supplied by VASCO DRUG LABORATORIES, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/us10119152-42-73-82?v=VASCO+DRUG+LABORATORIES
Average 90 stars, based on 1 article reviews
g77 strain - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection a-875
A 875, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/pmc10393547__mmc4-122-9-17?v=China+Center+for+Type+Culture+Collection
Average 90 stars, based on 1 article reviews
a-875 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics a375 cells
Exosomes derived from <t>A375</t> cells were more easily absorbed by human brain microvascular endothelial cells. ( A ) Schematic diagram of exosomes purification from tumor cells by differential centrifugation. ( B ) Western blotting showing protein level of exosomal markers (CD63, CD81) in 4 types of tumor cell-derived exosomes ( n = 3). ( C ) Representative TEM images of 4 types of tumor cell-derived exosomes ( n = 2). ( D ) Representative confocal images of hCMEC/D3 cells 24 h after incubation with exosomes (2 μg/mL and 10 μg/mL) derived from 4 different types of tumor cells ( n = 4). Exosomes were labeled by PKH67 (green) fluorescent dye. ( E ) Quantification of PKH67 fluorescence intensity for each group based on ( D ) ( n = 4). Data are presented as mean ± SEM, and are analyzed using a one-way ANOVA with Bonferroni post-test (***: p < 0.001).
A375 Cells, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/pmc08869810-53-0-2?v=iCell+Gene+Therapeutics
Average 90 stars, based on 1 article reviews
a375 cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Biomol GmbH human melanoma cell line a375
Effect of R428 on human <t>melanoma</t> <t>cell</t> <t>line</t> cell line <t>A375.</t> ( A , B ) The proliferation of the human breast cancer cell line A375 was significantly inhibited by R428 treatment. The results from the cell count assay ( A ) and the MTT assay ( B ) are shown. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05, ** p < 0.01. Some SEM values in the drug-treated experimental group that are too small to be shown are specified here: ( A ) 24 h. 0.009; 48 h, 0.012; 72 h, 0.006; 96 h, 0.000; (B) 24 h. 0.004; 48 h, 0.002; 72 h, 0.006; 96 h, 0.002. ( C , D ) The protein expression of METTL3 in the A375 cell line was significantly reduced by drug treatment, t -test, ** p < 0.01. The summary of Western blot grey values as the mean ± SEM from three independent experiments ( C ) and the representative Western blot result ( D ) are shown. ( E ) The RNA m6A modification level in the A375 cell line was significantly decreased after R428 treatment. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05. ( F , G ) Representative images of treated and control cells observed under an inverted 10× microscopy.
Human Melanoma Cell Line A375, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/pmc09690298-65-8-16?v=Biomol+GmbH
Average 90 stars, based on 1 article reviews
human melanoma cell line a375 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

a-375  (ATCC)
99
ATCC a-375
Effect of R428 on human <t>melanoma</t> <t>cell</t> <t>line</t> cell line <t>A375.</t> ( A , B ) The proliferation of the human breast cancer cell line A375 was significantly inhibited by R428 treatment. The results from the cell count assay ( A ) and the MTT assay ( B ) are shown. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05, ** p < 0.01. Some SEM values in the drug-treated experimental group that are too small to be shown are specified here: ( A ) 24 h. 0.009; 48 h, 0.012; 72 h, 0.006; 96 h, 0.000; (B) 24 h. 0.004; 48 h, 0.002; 72 h, 0.006; 96 h, 0.002. ( C , D ) The protein expression of METTL3 in the A375 cell line was significantly reduced by drug treatment, t -test, ** p < 0.01. The summary of Western blot grey values as the mean ± SEM from three independent experiments ( C ) and the representative Western blot result ( D ) are shown. ( E ) The RNA m6A modification level in the A375 cell line was significantly decreased after R428 treatment. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05. ( F , G ) Representative images of treated and control cells observed under an inverted 10× microscopy.
A 375, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/custom%40crl-1619%4020920165?v=ATCC
Average 99 stars, based on 1 article reviews
a-375 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

86
Procell Inc a375
TCPC inhibits melanoma cell proliferation, migration, and invasion in vitro. ( A ) Cell viability of <t>A375</t> and SK-MEL-28 cells treated with CTRL, PC, TC, or TCPC for 24 h measured by CCK-8 assay. ( B, C ) Wound healing assays of A375 and SK-MEL-28 cells after treatment. ( D, E ) Representative images and quantification of Transwell invasion assays in both cell lines. Scale bar = 200 μm. Data are shown as mean ± SD ( n = 3). Statistical significance was determined by two-sample t-test comparing each treatment group with CTRL. * p < 0.05, ** p < 0.01
A375, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/pmc12859999-24-1-8?v=Procell+Inc
Average 86 stars, based on 1 article reviews
a375 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Dr Raymond Laboratories Inc a375 human melanoma cells
TCPC inhibits melanoma cell proliferation, migration, and invasion in vitro. ( A ) Cell viability of <t>A375</t> and SK-MEL-28 cells treated with CTRL, PC, TC, or TCPC for 24 h measured by CCK-8 assay. ( B, C ) Wound healing assays of A375 and SK-MEL-28 cells after treatment. ( D, E ) Representative images and quantification of Transwell invasion assays in both cell lines. Scale bar = 200 μm. Data are shown as mean ± SD ( n = 3). Statistical significance was determined by two-sample t-test comparing each treatment group with CTRL. * p < 0.05, ** p < 0.01
A375 Human Melanoma Cells, supplied by Dr Raymond Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+melanoma+cell+lines+a375/pm10473806-41-0-8?v=Dr+Raymond+Laboratories+Inc
Average 90 stars, based on 1 article reviews
a375 human melanoma cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Exosomes derived from A375 cells were more easily absorbed by human brain microvascular endothelial cells. ( A ) Schematic diagram of exosomes purification from tumor cells by differential centrifugation. ( B ) Western blotting showing protein level of exosomal markers (CD63, CD81) in 4 types of tumor cell-derived exosomes ( n = 3). ( C ) Representative TEM images of 4 types of tumor cell-derived exosomes ( n = 2). ( D ) Representative confocal images of hCMEC/D3 cells 24 h after incubation with exosomes (2 μg/mL and 10 μg/mL) derived from 4 different types of tumor cells ( n = 4). Exosomes were labeled by PKH67 (green) fluorescent dye. ( E ) Quantification of PKH67 fluorescence intensity for each group based on ( D ) ( n = 4). Data are presented as mean ± SEM, and are analyzed using a one-way ANOVA with Bonferroni post-test (***: p < 0.001).

Journal: Biosensors

Article Title: Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model

doi: 10.3390/bios12020089

Figure Lengend Snippet: Exosomes derived from A375 cells were more easily absorbed by human brain microvascular endothelial cells. ( A ) Schematic diagram of exosomes purification from tumor cells by differential centrifugation. ( B ) Western blotting showing protein level of exosomal markers (CD63, CD81) in 4 types of tumor cell-derived exosomes ( n = 3). ( C ) Representative TEM images of 4 types of tumor cell-derived exosomes ( n = 2). ( D ) Representative confocal images of hCMEC/D3 cells 24 h after incubation with exosomes (2 μg/mL and 10 μg/mL) derived from 4 different types of tumor cells ( n = 4). Exosomes were labeled by PKH67 (green) fluorescent dye. ( E ) Quantification of PKH67 fluorescence intensity for each group based on ( D ) ( n = 4). Data are presented as mean ± SEM, and are analyzed using a one-way ANOVA with Bonferroni post-test (***: p < 0.001).

Article Snippet: A375 cells (iCell, #A375) were cultured in DMEM medium (Gibco, #C11995500BT) supplemented with 10% FBS and 1% P/S.

Techniques: Derivative Assay, Purification, Centrifugation, Western Blot, Incubation, Labeling, Fluorescence

A375 cell-derived exosomes caused BBB damage and glial activation. ( A ) Side views of the BBB chip 24 h later following exposure of A375 cell-derived exosomes (green) to the vascular side ( n = 3). ( B ) Representative confocal images of glial cells 24 h later following exposure of A375 cell-derived exosomes labeled by PKH67 dye to the vascular side ( n = 3). ( C ) BBB permeability assay of 10 kDa FITC-dextran following exposure of A375 cell-derived exosomes to the vascular side ( n = 4). Data are presented as mean ± SEM, and are analyzed using unpaired Student’s t -test (*: p < 0.05). ( D ) Representative confocal images of brain endothelial cells (VE-cadherin) 72 h later following treatment of A375 cell-derived exosomes ( n = 3). The areas indicated by the white boxes were enlarged on the right. ( E ) Western blotting showing the protein level of VE-cadherin and ZO-1 in brain endothelial cells 72 h later following treatment of A375 cell-derived exosomes ( n = 3). GAPDH was used as an internal control. ( F , G ) Representative confocal images of astrocytes (GFAP; F ) and microglia (IBA1; G ) 72 h later following treatment of A375 cell-derived exosomes ( n = 3). ( H ) Bar graph showing IL-6 concentration in culture supernatant of vascular channel 72 h later following exposure of A375 or A549 cell-derived exosomes to the vascular side detected by ELISA kit ( n = 3). ( I ) Bar graph showing IL-6 concentration in culture supernatant of glial channel 72 h later following exposure of A375 or A549 cell-derived exosomes to the vascular side detected by Elisa kit ( n = 3). ( H , I ) Data are presented as mean ± SEM, and are analyzed using a one-way ANOVA with Bonferroni post-test (**: p < 0.01; ***: p < 0.001). ( J ) Representative confocal images of brain endothelial cells and glial cells stained with PI dye 72 h later following treatment of A375 cell-derived exosomes. Cells positive for PI were indicated by white arrowheads ( n = 4). ( K ) Bar graph showing the percentage of PI + cells for each group based on ( J ) ( n = 4). Data are presented as mean ± SEM, and are analyzed using unpaired Student’s t -test (***: p < 0.001).

Journal: Biosensors

Article Title: Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model

doi: 10.3390/bios12020089

Figure Lengend Snippet: A375 cell-derived exosomes caused BBB damage and glial activation. ( A ) Side views of the BBB chip 24 h later following exposure of A375 cell-derived exosomes (green) to the vascular side ( n = 3). ( B ) Representative confocal images of glial cells 24 h later following exposure of A375 cell-derived exosomes labeled by PKH67 dye to the vascular side ( n = 3). ( C ) BBB permeability assay of 10 kDa FITC-dextran following exposure of A375 cell-derived exosomes to the vascular side ( n = 4). Data are presented as mean ± SEM, and are analyzed using unpaired Student’s t -test (*: p < 0.05). ( D ) Representative confocal images of brain endothelial cells (VE-cadherin) 72 h later following treatment of A375 cell-derived exosomes ( n = 3). The areas indicated by the white boxes were enlarged on the right. ( E ) Western blotting showing the protein level of VE-cadherin and ZO-1 in brain endothelial cells 72 h later following treatment of A375 cell-derived exosomes ( n = 3). GAPDH was used as an internal control. ( F , G ) Representative confocal images of astrocytes (GFAP; F ) and microglia (IBA1; G ) 72 h later following treatment of A375 cell-derived exosomes ( n = 3). ( H ) Bar graph showing IL-6 concentration in culture supernatant of vascular channel 72 h later following exposure of A375 or A549 cell-derived exosomes to the vascular side detected by ELISA kit ( n = 3). ( I ) Bar graph showing IL-6 concentration in culture supernatant of glial channel 72 h later following exposure of A375 or A549 cell-derived exosomes to the vascular side detected by Elisa kit ( n = 3). ( H , I ) Data are presented as mean ± SEM, and are analyzed using a one-way ANOVA with Bonferroni post-test (**: p < 0.01; ***: p < 0.001). ( J ) Representative confocal images of brain endothelial cells and glial cells stained with PI dye 72 h later following treatment of A375 cell-derived exosomes. Cells positive for PI were indicated by white arrowheads ( n = 4). ( K ) Bar graph showing the percentage of PI + cells for each group based on ( J ) ( n = 4). Data are presented as mean ± SEM, and are analyzed using unpaired Student’s t -test (***: p < 0.001).

Article Snippet: A375 cells (iCell, #A375) were cultured in DMEM medium (Gibco, #C11995500BT) supplemented with 10% FBS and 1% P/S.

Techniques: Derivative Assay, Activation Assay, Labeling, Permeability, Western Blot, Control, Concentration Assay, Enzyme-linked Immunosorbent Assay, Staining

RNA-seq analysis of brain endothelial cells and glial cells following treatment of A375 cell-derived exosomes on the BBB chip. ( A ) Heat-map showing the transcriptional changes of brain endothelial cells and glial cells on BBB chip 3 days after treatment of A375 cell-derived exosomes ( n = 3). ( B , C ) Volcano plots showed the modulated genes in brain endothelial cells ( B ) or glial cells ( C ) 3 days after treatment of A375 cell-derived exosomes. Genes differentially expressed with fold-change >1.5 and p < 0.05 were marked in color. p -values were calculated using a two-sided, unpaired Student’s t-test with equal variance assumed. ( D ) Venn diagrams depicted the down-regulated DEGs shared or unique between brain endothelial cells and glial cells. ( E ) Venn diagrams depicted the up-regulated DEGs shared or unique between brain endothelial cells and glial cells. ( F , G ) Dotplot showed the enriched GO terms based on up-regulated ( F ) or down-regulated ( G ) genes in brain endothelial cells following treatment of A375 cell-derived exosomes. ( H , I ) Dotplot showed the enriched GO terms based on up-regulated ( H ) or down-regulated ( I ) genes in glial cells following treatment of A375 cell-derived exosomes. ( F – I ) The color of the dots represents the rich factor, and the size represents the input number for each GO term.

Journal: Biosensors

Article Title: Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model

doi: 10.3390/bios12020089

Figure Lengend Snippet: RNA-seq analysis of brain endothelial cells and glial cells following treatment of A375 cell-derived exosomes on the BBB chip. ( A ) Heat-map showing the transcriptional changes of brain endothelial cells and glial cells on BBB chip 3 days after treatment of A375 cell-derived exosomes ( n = 3). ( B , C ) Volcano plots showed the modulated genes in brain endothelial cells ( B ) or glial cells ( C ) 3 days after treatment of A375 cell-derived exosomes. Genes differentially expressed with fold-change >1.5 and p < 0.05 were marked in color. p -values were calculated using a two-sided, unpaired Student’s t-test with equal variance assumed. ( D ) Venn diagrams depicted the down-regulated DEGs shared or unique between brain endothelial cells and glial cells. ( E ) Venn diagrams depicted the up-regulated DEGs shared or unique between brain endothelial cells and glial cells. ( F , G ) Dotplot showed the enriched GO terms based on up-regulated ( F ) or down-regulated ( G ) genes in brain endothelial cells following treatment of A375 cell-derived exosomes. ( H , I ) Dotplot showed the enriched GO terms based on up-regulated ( H ) or down-regulated ( I ) genes in glial cells following treatment of A375 cell-derived exosomes. ( F – I ) The color of the dots represents the rich factor, and the size represents the input number for each GO term.

Article Snippet: A375 cells (iCell, #A375) were cultured in DMEM medium (Gibco, #C11995500BT) supplemented with 10% FBS and 1% P/S.

Techniques: RNA Sequencing, Derivative Assay

Effect of R428 on human melanoma cell line cell line A375. ( A , B ) The proliferation of the human breast cancer cell line A375 was significantly inhibited by R428 treatment. The results from the cell count assay ( A ) and the MTT assay ( B ) are shown. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05, ** p < 0.01. Some SEM values in the drug-treated experimental group that are too small to be shown are specified here: ( A ) 24 h. 0.009; 48 h, 0.012; 72 h, 0.006; 96 h, 0.000; (B) 24 h. 0.004; 48 h, 0.002; 72 h, 0.006; 96 h, 0.002. ( C , D ) The protein expression of METTL3 in the A375 cell line was significantly reduced by drug treatment, t -test, ** p < 0.01. The summary of Western blot grey values as the mean ± SEM from three independent experiments ( C ) and the representative Western blot result ( D ) are shown. ( E ) The RNA m6A modification level in the A375 cell line was significantly decreased after R428 treatment. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05. ( F , G ) Representative images of treated and control cells observed under an inverted 10× microscopy.

Journal: Genes

Article Title: Integrative Transcriptomic Analysis Identify Potential m6A Pathway-Related Drugs That Inhibit Cancer Cell Proliferation

doi: 10.3390/genes13112011

Figure Lengend Snippet: Effect of R428 on human melanoma cell line cell line A375. ( A , B ) The proliferation of the human breast cancer cell line A375 was significantly inhibited by R428 treatment. The results from the cell count assay ( A ) and the MTT assay ( B ) are shown. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05, ** p < 0.01. Some SEM values in the drug-treated experimental group that are too small to be shown are specified here: ( A ) 24 h. 0.009; 48 h, 0.012; 72 h, 0.006; 96 h, 0.000; (B) 24 h. 0.004; 48 h, 0.002; 72 h, 0.006; 96 h, 0.002. ( C , D ) The protein expression of METTL3 in the A375 cell line was significantly reduced by drug treatment, t -test, ** p < 0.01. The summary of Western blot grey values as the mean ± SEM from three independent experiments ( C ) and the representative Western blot result ( D ) are shown. ( E ) The RNA m6A modification level in the A375 cell line was significantly decreased after R428 treatment. Data represented the mean ± SEM from five independent experiments, t -test, * p < 0.05. ( F , G ) Representative images of treated and control cells observed under an inverted 10× microscopy.

Article Snippet: The breast cancer cell line MCF7 and the human melanoma cell line A375 were provided by Biomol Inc. (Hamburg, Germany).

Techniques: Cell Counting, MTT Assay, Expressing, Western Blot, Modification, Control, Microscopy

TCPC inhibits melanoma cell proliferation, migration, and invasion in vitro. ( A ) Cell viability of A375 and SK-MEL-28 cells treated with CTRL, PC, TC, or TCPC for 24 h measured by CCK-8 assay. ( B, C ) Wound healing assays of A375 and SK-MEL-28 cells after treatment. ( D, E ) Representative images and quantification of Transwell invasion assays in both cell lines. Scale bar = 200 μm. Data are shown as mean ± SD ( n = 3). Statistical significance was determined by two-sample t-test comparing each treatment group with CTRL. * p < 0.05, ** p < 0.01

Journal: Journal of Nanobiotechnology

Article Title: Engineering endoplasmic reticulum targeted metal–polyphenol curcumin nanomicelles for melanoma therapy

doi: 10.1186/s12951-025-03941-7

Figure Lengend Snippet: TCPC inhibits melanoma cell proliferation, migration, and invasion in vitro. ( A ) Cell viability of A375 and SK-MEL-28 cells treated with CTRL, PC, TC, or TCPC for 24 h measured by CCK-8 assay. ( B, C ) Wound healing assays of A375 and SK-MEL-28 cells after treatment. ( D, E ) Representative images and quantification of Transwell invasion assays in both cell lines. Scale bar = 200 μm. Data are shown as mean ± SD ( n = 3). Statistical significance was determined by two-sample t-test comparing each treatment group with CTRL. * p < 0.05, ** p < 0.01

Article Snippet: The A375 and SK-MEL-28 line were obtained from Procell (Procell, China).

Techniques: Migration, In Vitro, CCK-8 Assay

Transcriptomic analysis reveals ER stress induction by TCPC in melanoma cells. ( A ) PCA plot showing clear separation between CTRL and TCPC-treated A375 cells. ( B ) Volcano plot of DEGs. ( C ) Bar chart summarizing upregulated and downregulated DEGs. ( D ) Heatmap of representative DEGs. ( E ) GO enrichment analysis highlighting ER-related terms in the cellular component category. ( F ) GSEA enrichment plots of top pathways after TCPC treatment. ( G ) Enrichment plot for “response to ER stress” pathway. Data are presented as mean ± SD ( n = 5)

Journal: Journal of Nanobiotechnology

Article Title: Engineering endoplasmic reticulum targeted metal–polyphenol curcumin nanomicelles for melanoma therapy

doi: 10.1186/s12951-025-03941-7

Figure Lengend Snippet: Transcriptomic analysis reveals ER stress induction by TCPC in melanoma cells. ( A ) PCA plot showing clear separation between CTRL and TCPC-treated A375 cells. ( B ) Volcano plot of DEGs. ( C ) Bar chart summarizing upregulated and downregulated DEGs. ( D ) Heatmap of representative DEGs. ( E ) GO enrichment analysis highlighting ER-related terms in the cellular component category. ( F ) GSEA enrichment plots of top pathways after TCPC treatment. ( G ) Enrichment plot for “response to ER stress” pathway. Data are presented as mean ± SD ( n = 5)

Article Snippet: The A375 and SK-MEL-28 line were obtained from Procell (Procell, China).

Techniques:

TCPC induces ER stress–mediated apoptosis through Ca²⁺ overload and mitochondrial dysfunction. ( A ) qPCR analysis of ER stress–related genes (CHOP, HSPA5, TTC23L) in A375 and SK-MEL-28 cells. ( B ) Confocal imaging confirming CHOP protein upregulation. Scale bar = 20 μm. ( C ) TEM images showing ER swelling in TCPC-treated cells. Scale bars: 5 μm and 1 μm. ( D, E ) ER-Tracker staining and flow cytometry quantification of ER expansion. Scale bar = 20 μm. (F, G ) Intracellular Ca²⁺ changes visualized by confocal microscopy. Scale bar = 20 μm. (H ) JC-1 staining showing loss of mitochondrial membrane potential. Scale bar = 20 μm. (I, J) Intracellular ROS levels after TCPC treatment. Scale bar = 20 μm. ( K ) Flow cytometry analysis of apoptosis. Data are shown as mean ± SD ( n = 3). Statistical significance was determined by two-sample t-test comparing with CTRL group. * p < 0.05, ** p < 0.01

Journal: Journal of Nanobiotechnology

Article Title: Engineering endoplasmic reticulum targeted metal–polyphenol curcumin nanomicelles for melanoma therapy

doi: 10.1186/s12951-025-03941-7

Figure Lengend Snippet: TCPC induces ER stress–mediated apoptosis through Ca²⁺ overload and mitochondrial dysfunction. ( A ) qPCR analysis of ER stress–related genes (CHOP, HSPA5, TTC23L) in A375 and SK-MEL-28 cells. ( B ) Confocal imaging confirming CHOP protein upregulation. Scale bar = 20 μm. ( C ) TEM images showing ER swelling in TCPC-treated cells. Scale bars: 5 μm and 1 μm. ( D, E ) ER-Tracker staining and flow cytometry quantification of ER expansion. Scale bar = 20 μm. (F, G ) Intracellular Ca²⁺ changes visualized by confocal microscopy. Scale bar = 20 μm. (H ) JC-1 staining showing loss of mitochondrial membrane potential. Scale bar = 20 μm. (I, J) Intracellular ROS levels after TCPC treatment. Scale bar = 20 μm. ( K ) Flow cytometry analysis of apoptosis. Data are shown as mean ± SD ( n = 3). Statistical significance was determined by two-sample t-test comparing with CTRL group. * p < 0.05, ** p < 0.01

Article Snippet: The A375 and SK-MEL-28 line were obtained from Procell (Procell, China).

Techniques: Imaging, Staining, Flow Cytometry, Confocal Microscopy, Membrane

In vivo antitumor efficacy of TCPC in a melanoma xenograft model. ( A ) Schematic of the treatment schedule in A375 tumor–bearing nude mice. ( B, C ) Tumor volume growth curves and tumor weights after treatment. ( D ) H&E staining of tumor tissues showing apoptosis and necrosis. ( E, F, H, I ) IHC staining for cleaved caspase-3 and Ki-67 in tumor sections. ( G, J ) IHC staining showing increased CHOP expression in TCPC-treated tumors. Scale bar = 100 μm. Data are shown as mean ± SD ( n = 5), Statistical significance was determined by two-sample t-test comparing with CTRL group. * p < 0.05, ** p < 0.01

Journal: Journal of Nanobiotechnology

Article Title: Engineering endoplasmic reticulum targeted metal–polyphenol curcumin nanomicelles for melanoma therapy

doi: 10.1186/s12951-025-03941-7

Figure Lengend Snippet: In vivo antitumor efficacy of TCPC in a melanoma xenograft model. ( A ) Schematic of the treatment schedule in A375 tumor–bearing nude mice. ( B, C ) Tumor volume growth curves and tumor weights after treatment. ( D ) H&E staining of tumor tissues showing apoptosis and necrosis. ( E, F, H, I ) IHC staining for cleaved caspase-3 and Ki-67 in tumor sections. ( G, J ) IHC staining showing increased CHOP expression in TCPC-treated tumors. Scale bar = 100 μm. Data are shown as mean ± SD ( n = 5), Statistical significance was determined by two-sample t-test comparing with CTRL group. * p < 0.05, ** p < 0.01

Article Snippet: The A375 and SK-MEL-28 line were obtained from Procell (Procell, China).

Techniques: In Vivo, Staining, Immunohistochemistry, Expressing